Sunglow Lifescience Profile
Key Indicators
- Authorised Capital ₹ 21.00 Cr
as on 01-07-2024
- Paid Up Capital ₹ 20.45 Cr
as on 01-07-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 29.62 Cr
as on 01-07-2024
- Revenue -9.61%
(FY 2023)
- Profit -33.92%
(FY 2023)
- Ebitda -20.91%
(FY 2023)
- Net Worth 9.20%
(FY 2023)
- Total Assets 7.27%
(FY 2023)
About Sunglow Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 21.00 Cr and a paid-up capital of Rs 20.45 Cr.
The company currently has active open charges totaling ₹29.62 Cr.
The Key Managerial Personnel (KMP) at Sunglow Lifescience Private Limited India is Thynes Jeyaprakasam as COMPANY SECRETARY. Rajasekar Nagamallu, Kamaraj, Veerabadran Rajasekaran, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100TN2012PTC087894
- Company No.
087894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2012
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sunglow Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thynes Jeyaprakasam | Company Secretary | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veerabadran Rajasekaran  | Director | 09-Sep-2013 | Current |
| Rajasekar Nagamallu | Director | 28-Jul-2021 | Current |
| Kamaraj | Director | 01-Oct-2012 | Current |
S Bhandari  | Director | 28-Nov-2013 | Current |
Financial Performance of Sunglow Lifescience.
Sunglow Lifescience Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.61% decrease. The company also saw a substantial fall in profitability, with a 33.92% decrease in profit. The company's net worth moved up by a moderate rise of 9.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunglow Lifescience?
In 2023, Sunglow Lifescience had a promoter holding of 13.69% and a public holding of 86.31%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Pace Builders (Madras) Private LimitedActive 27 years 7 monthsRajasekar Nagamallu is a mutual person
- Sunglow Pharmaceuticalss Private LimitedActive 14 years 11 months
Kamaraj and Veerabadran Rajasekaran are mutual person
- Relimed Pharmaceuticals Private LimitedActive 13 years 11 months
Kamaraj and Veerabadran Rajasekaran are mutual person
- Adiramedica Private LimitedActive 3 months 27 days
Veerabadran Rajasekaran and S Bhandari are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 23 Jul 2020 | ₹16.17 Cr | Open |
Axis Bank Limited Creation Date: 28 Feb 2017 | ₹13.45 Cr | Open |
How Many Employees Work at Sunglow Lifescience?
Sunglow Lifescience has a workforce of 109 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunglow Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunglow Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
